Curaleaf International Sets APAC Benchmark: First TGA-Approved Inhalation Device
Curaleaf International has officially secured a major regulatory victory in Australia, achieving the country’s first-ever Therapeutic Goods Administration (TGA) registration for a liquid medical cannabis inhalation device. This pivotal development not only establishes a new benchmark for clinical-grade delivery systems in the Australian medical cannabis market but also underscores the company’s aggressive and strategic expansion…

